ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,959,866 | +55.1% | 68,203 | +43.8% | 0.25% | +73.8% |
| Q2 2023 | $2,553,839 | +186.9% | 47,443 | +72.4% | 0.14% | +281.6% |
| Q2 2020 | $890,000 | -21.2% | 27,526 | -0.7% | 0.04% | -39.7% |
| Q1 2020 | $1,130,000 | -34.4% | 27,726 | -0.8% | 0.06% | +8.6% |
| Q4 2019 | $1,723,000 | -17.5% | 27,943 | -2.5% | 0.06% | -22.7% |
| Q3 2019 | $2,088,000 | -3.5% | 28,649 | +8.9% | 0.08% | +4.2% |
| Q2 2019 | $2,163,000 | +9.9% | 26,314 | -5.7% | 0.07% | +14.3% |
| Q1 2019 | $1,969,000 | +50.1% | 27,914 | -4.2% | 0.06% | +31.2% |
| Q4 2018 | $1,312,000 | -11.4% | 29,139 | +11.3% | 0.05% | -9.4% |
| Q3 2018 | $1,481,000 | -31.5% | 26,192 | -19.1% | 0.05% | -32.9% |
| Q2 2018 | $2,163,000 | +34.8% | 32,378 | -0.1% | 0.08% | +1.3% |
| Q1 2017 | $1,605,000 | -20.1% | 32,426 | -2.1% | 0.08% | -22.8% |
| Q4 2016 | $2,008,000 | -9.2% | 33,126 | -0.6% | 0.10% | -12.9% |
| Q3 2016 | $2,211,000 | – | 33,326 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |